Search research articles
Contact Us
Filters
Showing results (691-700 of 20,797) with videos related to
Page
of 2,080
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2009
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?
Alicia Okines, David Cunningham
Journal of Renal Care
|
February 19, 2009
Soft bones and hard arteries-can we reverse the trend in CKD?
James Tomlinson, John Cunningham
The FEBS Journal
|
May 25, 2007
Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes
Amaury Herpin, Charles Cunningham
Healthcare Policy = Politiques De Sante
|
March 24, 2009
The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia
Steve Morgan, Colleen Cunningham
Healthcare Policy = Politiques De Sante
|
March 24, 2009
The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia
Steve Morgan, Colleen Cunningham
Nursing Children and Young People
|
December 7, 2013
Guidelines for routine gastrostomy tube replacement in children
Sarah Cunningham, Carolyn Best
Disasters
|
July 24, 2013
Introduction to the issue of state sovereignty and humanitarian action
Clea Kahn, Andrew Cunningham
Frontiers in Bioscience (Elite Edition)
|
June 11, 2013
Wheezing defined
Dimos Gidaris, Steve Cunningham
Clinical Colorectal Cancer
|
April 12, 2008
A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patients
Christopher Jackson, David Cunningham
Journal of Geriatric Oncology
|
February 4, 2014
Bevacizumab in elderly patients with metastatic colorectal cancer
Francesco Sclafani, David Cunningham
Page
of 2,080
Search research articles
Search
Showing results (691-700 of 20,797) with videos related to
Sort By:
Page
of 2,080
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 2009
Current perspective: bevacizumab in colorectal cancer--a time for reappraisal?
Alicia Okines, David Cunningham
Journal of Renal Care
|
February 19, 2009
Soft bones and hard arteries-can we reverse the trend in CKD?
James Tomlinson, John Cunningham
The FEBS Journal
|
May 25, 2007
Cross-talk between the bone morphogenetic protein pathway and other major signaling pathways results in tightly regulated cell-specific outcomes
Amaury Herpin, Charles Cunningham
Healthcare Policy = Politiques De Sante
|
March 24, 2009
The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia
Steve Morgan, Colleen Cunningham
Healthcare Policy = Politiques De Sante
|
March 24, 2009
The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia
Steve Morgan, Colleen Cunningham
Nursing Children and Young People
|
December 7, 2013
Guidelines for routine gastrostomy tube replacement in children
Sarah Cunningham, Carolyn Best
Disasters
|
July 24, 2013
Introduction to the issue of state sovereignty and humanitarian action
Clea Kahn, Andrew Cunningham
Frontiers in Bioscience (Elite Edition)
|
June 11, 2013
Wheezing defined
Dimos Gidaris, Steve Cunningham
Clinical Colorectal Cancer
|
April 12, 2008
A retrospective on the inhibition of epidermal growth factor receptor as a therapeutic strategy for patients with relapsed metastatic colorectal cancer: impact on treatment of today's patients
Christopher Jackson, David Cunningham
Journal of Geriatric Oncology
|
February 4, 2014
Bevacizumab in elderly patients with metastatic colorectal cancer
Francesco Sclafani, David Cunningham
Page
of 2,080